A similar observation was made by Maglione et al., who discovered that one and six months after immunization against SARS-CoV-2, the concentration of interferon-gamma was comparable in groups of patients with MS treated with dimethyl fumarate (DMF), IFN beta, and the general population [62]. Here, IFNG is linked to myeloid sarcoma.